Table 3.
Synergistic effect of AgNPs with antibiotics and the target microbes
| Target pathogen | AgNPs + Antibiotic (synergistic effect) | AgNP morphology | Key references |
|---|---|---|---|
| Staphylococcus aureus | Amoxycillin | Size: variable Shape: spherical |
Silvero et al. (2018) |
| Candida albicans | Fluconazole | Size: 30 ± 1 nm Shape: Spherical |
El-Adly and Shabana (2018) |
| Klebsiella pneumonia, Staphylococcus epidermidis and Staphylococcus aureus | Gentamycin | Size: 8–45 nm Shape: spherical |
Kumar et al. (2018) |
| Bacillus cereus, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa | Ceftriaxone | Size: 20 nm Shape: spherical |
Shanmuganathan et al. (2018) |
| Candida albicans | Ketoconazole | Size: 10–15 nm Shape: spherical |
Prasher et al. (2018a, b) |
| Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis, followed by Escherichia coli, Klebsiella pneumoniae, and Bacillus subtilis | Streptomycin, gentamycin, kanamycin, ampicillin, tetracycline and neomycin | Size: 8–48 nm Shape: spherical |
Buszewski et al. (2018a, b) |
| Acinetobacter baumannii | Doxycycline, tetracycline and erythromycin | Size: variable Shape: variable |
Singh et al. (2018) |
| Enterococcus faecalis | Gentamycin and Chloramphenicol | Size: 20 nm (avg.) Shape: variable |
Katva et al. (2017) |
| Mycobacterium tuberculosis | Rifampicin | Size: 12 nm (avg.) Shape: spherical and cluster |
Jafari et al. (2017) |
| Pseudomonas aeruginosa Biofilms | Tobramycin | Size: 10–20 nm Shape: variable |
Habash et al. (2017) |
| Escherichia coli and Staphylococcus aureus | Vancomycin, Streptomycin, Tetracycline, gentamycin, Amoxycillin, Erythromycin, ciprofloxacin | Size: 15 nm Shape: variable |
Saratale et al. (2017) |
| Serratia marcescens | Ampicillin and penicillin | Size: 2–5 nm Shape: spherical |
Kumari et al. (2017) |
| Candida albicans Candida glabrata, Candida geochares, Candida saitoana, Bacillus cereus, Escherichia coli, Staphylococcus aureus, Listeria monocytogenes, Salmonella typhimurium | Amphotericin B, Kanamycin, Rifampicin | Not available | Patra and Baek (2017) |
| Staphylococcus aureus and Escherichia coli | Ampicillin | Size: 20–170 nm Shape: variable |
Tippayawat et al. (2017) |
| Bacillus cereus, Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella typhimurium and Vibrio vulnificus | Amoxycillin, Ampicillin, Erythromycin, Kanamycin, Tetracycline | Size: 5–15 nm Shape: spherical |
Prema et al. (2017) |
| Gram-positive and Gram-negative bacteria | Cephalexin | Size: 21 ± 5 nm (avg.) Shape: spherical |
Wang et al. (2017a, b, c) |
| Escherichia coli and Staphylococcus aureus | Penicillin, kanamycin, chloramphenicol, ampicillin | Size: 20–167 nm Shape: variable |
Kaweeteerawat et al. (2017) |
| Pseudomonas aeruginosa, Escherichia coli, Bacillus subtilis, Staphylococcus aureus | Curcumin | Size: 25–35 nm Shape: variable |
Jaiswal and Mishra (2017) |
| Microcystis aeruginosa and Phormidium sp. | Gentamycin, ampicillin | Size: 71–201 nm Shape: variable |
Satapathy et al. (2017) |
| Staphylococcus aureus, Vibrio cholera | Ampicillin and ciprofloxacin | Size: 35–60 nm Shape: variable |
Naik et al. (2017) |
| Candida albicans, Malassezia furfur, and Trichophyton erinacei | Fluconazole, ketoconazole | Size: 12.7 nm (avg.) Shape: spherical |
Wypij et al. (2017a, b) |
| Staphylococcus aureus, Escherichia coli | Ciprofloxacin | Not available | Ibrahim et al. (2017) |
| Staphylococcus aureus and Bacillus subtilis, Proteus vulgaris | Vancomycin, Gentamycin, Amikacin, Linezolid | Size: 72–85 nm Shape: variable |
Rangarajan et al. (2017) |
| Bacillus cereus, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli | Ampicillin, Polymyxin, Gentamicin, Chloramphenicol, Penicillin, Amikacin, Tetracycline, Cephalothin, Amoxyclav, Cefpirome, Clotrimazole | Size: 15–20 nm Shape: variable |
Moteria et al. (2017) |
| Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Klebsiella pneumoniae | Ampicillin, chloramphenicol, streptomycin and tetracycline | Size:7.22 ± 3.7 nm (avg.) Shape: variable |
Phanjom and Ahmed (2017) |
| Klebsiella pneumoniae | Gentamycin | Not available | Chibber et al. (2017) |
| Escherichia coli, Staphylococcus aureus | Ciprofloxacin | Size:17 nm (avg.) Shape: not available |
Xiong et al. (2017) |
| Actinobacillus pleuropneumoniae. Actinobacillus pleuropneumoniae and Pasteurella multocida | Penicillin, Gentamycin, Colistin | Size:8 nm and 28 nm Shape: spherical |
Smekalova et al. (2016) |
| Enterobacteriaceae | Cefotaxime, ceftazidime, meropenem, ciprofloxacin and gentamicin | Size: 28 nm Shape: spherical |
Panacek et al. (2016) |
| Bacillus cereus 4079, Staphylococcus epidermidis 3615, Staphylococcus aureus 740, Bacillus subtilis 441, Escherichia coli 443, Salmonella typhimurium 98, Klebsiella pneumoniae 3384, Serratia marcescens 97 | Streptomycin, Amikacin, Kanamycin, Vancomycin, Tetracycline, Ampicillin, Cefepime, Amoxicillin, Cefetaxime | Size: 20–30 nm Shape: FCC cubic |
Jyoti et al. (2016) |
| Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus and Bacillus subtilis | Kanamycin, Ampicillin, Tetracycline | Size: 5–50 nm Shape:spherical |
Rathod et al. (2016) |
| Escherichia coli, Klebsiella pneumoniae, Bacillus subtilis, Staphylococcus aureus, Pseudomonas aeruginosa | Kanamycin, Tetracycline, Ampicillin | Size: 12.7–15.9 nm Shape:spherical |
Golinska et al. (2016a, b) |
| Staphylococcus aureus | Neomycin, Gentamycin | Not available | Jamaran and Zarif (2016) |
| Klebsiella pneumoniae, Pseudomonas brassicacearum, Aeromonas hydrophila, Escherichia coli, Bacillus cereus, Staphylococcus aureus, Candida albicans, Fusarium oxysporum, and Aspergillus flavus | Streptomycin, tetracycline, kanamycin, rifampicin, amphotericin B, fluconazole, and ketoconazole | 5–30 nm Spherical |
Aziz et al. (2016) |